• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制剂结合的 SARS-CoV-2 木瓜蛋白酶样蛋白酶的活性分析和晶体结构:抗 COVID-19 药物设计的框架。

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.

机构信息

Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wyb. Wyspianskiego 27, 50-370 Wroclaw, Poland.

Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Sci Adv. 2020 Oct 16;6(42). doi: 10.1126/sciadv.abd4596. Print 2020 Oct.

DOI:10.1126/sciadv.abd4596
PMID:33067239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7567588/
Abstract

Viral papain-like cysteine protease (PLpro, NSP3) is essential for SARS-CoV-2 replication and represents a promising target for the development of antiviral drugs. Here, we used a combinatorial substrate library and performed comprehensive activity profiling of SARS-CoV-2 PLpro. On the scaffold of the best hits from positional scanning, we designed optimal fluorogenic substrates and irreversible inhibitors with a high degree of selectivity for SARS PLpro. We determined crystal structures of two of these inhibitors in complex with SARS-CoV-2 PLpro that reveals their inhibitory mechanisms and provides a molecular basis for the observed substrate specificity profiles. Last, we demonstrate that SARS-CoV-2 PLpro harbors deISGylating activity similar to SARSCoV-1 PLpro but its ability to hydrolyze K48-linked Ub chains is diminished, which our sequence and structure analysis provides a basis for. Together, this work has revealed the molecular rules governing PLpro substrate specificity and provides a framework for development of inhibitors with potential therapeutic value or drug repurposing.

摘要

病毒木瓜蛋白酶样半胱氨酸蛋白酶 (PLpro,NSP3) 是 SARS-CoV-2 复制所必需的,是开发抗病毒药物的有希望的靶点。在这里,我们使用组合底物文库对 SARS-CoV-2 PLpro 进行了全面的活性分析。在位置扫描最佳命中的支架上,我们设计了最佳荧光底物和对 SARS PLpro 具有高选择性的不可逆抑制剂。我们确定了其中两种抑制剂与 SARS-CoV-2 PLpro 复合物的晶体结构,揭示了它们的抑制机制,并为观察到的底物特异性提供了分子基础。最后,我们证明 SARS-CoV-2 PLpro 具有与 SARS-CoV-1 PLpro 相似的去泛素化酶 (deISGylating) 活性,但水解 K48 连接的 Ub 链的能力降低,我们的序列和结构分析为此提供了依据。总之,这项工作揭示了调控 PLpro 底物特异性的分子规则,并为具有潜在治疗价值或药物再利用的抑制剂的开发提供了框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ae5c1f9844fa/abd4596-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/7cf709852380/abd4596-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ce352523bb22/abd4596-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/9043e7a1d4f3/abd4596-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ae90c1e49a6f/abd4596-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ae5c1f9844fa/abd4596-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/7cf709852380/abd4596-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ce352523bb22/abd4596-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/9043e7a1d4f3/abd4596-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ae90c1e49a6f/abd4596-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d6/7567588/ae5c1f9844fa/abd4596-F5.jpg

相似文献

1
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.抑制剂结合的 SARS-CoV-2 木瓜蛋白酶样蛋白酶的活性分析和晶体结构:抗 COVID-19 药物设计的框架。
Sci Adv. 2020 Oct 16;6(42). doi: 10.1126/sciadv.abd4596. Print 2020 Oct.
2
Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design.与抑制剂结合的新型冠状病毒木瓜蛋白酶样蛋白酶的活性分析及结构为抗新冠病毒药物设计提供了框架。
bioRxiv. 2020 Apr 29:2020.04.29.068890. doi: 10.1101/2020.04.29.068890.
3
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.新型冠状病毒木瓜样蛋白酶的去泛素酶和去ISG15酶活性的表征及非共价抑制作用
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. doi: 10.1021/acsinfecdis.0c00168. Epub 2020 Jun 4.
4
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation.通过分子对接、分子动力学模拟和自由能计算对 COVID-19 主蛋白酶抑制剂的合理方法。
Sci Rep. 2020 Oct 19;10(1):17716. doi: 10.1038/s41598-020-74468-0.
5
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.鉴定 SARS-CoV-2 主蛋白酶的高亲和力抑制剂:迈向有效的 COVID-19 治疗。
Virus Res. 2020 Oct 15;288:198102. doi: 10.1016/j.virusres.2020.198102. Epub 2020 Jul 24.
6
Optimization Rules for SARS-CoV-2 M Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.SARS-CoV-2 M 抗病毒药物的优化规则:冠状病毒蛋白酶活性位点的整体对接和探索。
Viruses. 2020 Aug 26;12(9):942. doi: 10.3390/v12090942.
7
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.基于与病毒蛋白酶分子相互作用的抗 SARS-CoV 药物的设计与评估。
Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920.
8
Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒nsp3木瓜蛋白酶样蛋白酶结构域的催化功能及底物特异性
J Virol. 2014 Nov;88(21):12511-27. doi: 10.1128/JVI.01294-14. Epub 2014 Aug 20.
9
Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.严重急性呼吸综合征冠状病毒木瓜样蛋白酶的泛素连接特异性和去ISGylation活性的结构基础
PLoS Pathog. 2014 May 22;10(5):e1004113. doi: 10.1371/journal.ppat.1004113. eCollection 2014 May.
10
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.通过计算药物再利用研究快速鉴定可能用于治疗冠状病毒病 19(COVID-19)的药物。
J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4.

引用本文的文献

1
Multitarget-based screening from phytoactive compounds of fighting toward severe acute respiratory syndrome coronavirus-2.基于多靶点从抗严重急性呼吸综合征冠状病毒2的植物活性化合物中进行筛选
Tzu Chi Med J. 2025 Apr 4;37(3):275-284. doi: 10.4103/tcmj.tcmj_226_24. eCollection 2025 Jul-Sep.
2
Integrating Molecular Dynamics, Molecular Docking, and Machine Learning for Predicting SARS-CoV-2 Papain-like Protease Binders.整合分子动力学、分子对接和机器学习以预测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶结合物
Molecules. 2025 Jul 16;30(14):2985. doi: 10.3390/molecules30142985.
3
Structure-Based Design and In-Silico Evaluation of Computationally Proposed Curcumin Derivatives as Potential Inhibitors of the Coronaviral PLpro Enzymes.

本文引用的文献

1
Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes.用于优化去泛素化酶检测的工程化非天然泛素
Chem Sci. 2020 May 27;11(23):6058-6069. doi: 10.1039/d0sc01347a. eCollection 2020 Jun 21.
2
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.SARS-CoV-2 木瓜蛋白酶样蛋白酶(PLpro)的作用机制及抑制作用。
EMBO J. 2020 Sep 15;39(18):e106275. doi: 10.15252/embj.2020106275. Epub 2020 Aug 26.
3
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
基于结构的计算设计及虚拟评估姜黄素衍生物作为冠状病毒PLpro酶潜在抑制剂的研究
Pharmaceuticals (Basel). 2025 May 26;18(6):798. doi: 10.3390/ph18060798.
4
Drug discovery and development targeting the life cycle of SARS-CoV-2.针对新型冠状病毒生命周期的药物发现与开发。
Fundam Res. 2021 Mar;1(2):151-165. doi: 10.1016/j.fmre.2021.01.013. Epub 2021 Feb 1.
5
Host-Directed Therapies Based on Protease Inhibitors to Control and HIV Coinfection.基于蛋白酶抑制剂的宿主导向疗法以控制结核与HIV合并感染。
Microorganisms. 2025 Apr 30;13(5):1040. doi: 10.3390/microorganisms13051040.
6
Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease.新型冠状病毒木瓜样蛋白酶天然存在的耐药性突变的鉴定
Nat Commun. 2025 May 16;16(1):4548. doi: 10.1038/s41467-025-59922-9.
7
Precision spatiotemporal analysis of large-scale compound-protein interactions through molecular dynamics simulation.通过分子动力学模拟对大规模复合蛋白相互作用进行精确的时空分析。
PNAS Nexus. 2025 Mar 22;4(3):pgaf094. doi: 10.1093/pnasnexus/pgaf094. eCollection 2025 Mar.
8
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.结构病毒学:抗病毒治疗药物研发中的关键决定因素
Viruses. 2025 Mar 14;17(3):417. doi: 10.3390/v17030417.
9
Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶荧光偏振检测方法的开发。
ACS Pharmacol Transl Sci. 2025 Feb 26;8(3):774-784. doi: 10.1021/acsptsci.4c00642. eCollection 2025 Mar 14.
10
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates.喹啉类新型冠状病毒木瓜样蛋白酶抑制剂作为口服抗病毒候选药物的设计
Nat Commun. 2025 Feb 13;16(1):1604. doi: 10.1038/s41467-025-56902-x.
新型冠状病毒木瓜样蛋白酶的去泛素酶和去ISG15酶活性的表征及非共价抑制作用
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109. doi: 10.1021/acsinfecdis.0c00168. Epub 2020 Jun 4.
4
Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.对黄病毒 NS2B-NS3 蛋白酶特异性的分析为开发选择性化学工具提供了结构基础,这些工具可区分登革热病毒、寨卡病毒和西尼罗河病毒。
Antiviral Res. 2020 Mar;175:104731. doi: 10.1016/j.antiviral.2020.104731. Epub 2020 Jan 31.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
7
Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples.用于在细胞和血液样本中成像人组成型 20S 蛋白酶体的选择性底物和基于活性的探针。
J Med Chem. 2018 Jun 28;61(12):5222-5234. doi: 10.1021/acs.jmedchem.8b00026. Epub 2018 Jun 9.
8
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.基于反应活性位点的化学生物学蛋白质组学鉴定了一类独特的去泛素化酶。
Nat Commun. 2018 Mar 21;9(1):1162. doi: 10.1038/s41467-018-03511-6.
9
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.二硫化硒可通过不同模式抑制 MERS 和 SARS 冠状病毒木瓜蛋白酶样蛋白酶。
Antiviral Res. 2018 Feb;150:155-163. doi: 10.1016/j.antiviral.2017.12.015. Epub 2017 Dec 28.
10
Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity.合成 HyCoSuL 肽底物文库以剖析蛋白酶底物特异性。
Nat Protoc. 2017 Oct;12(10):2189-2214. doi: 10.1038/nprot.2017.091. Epub 2017 Sep 21.